Editas Medicine (EDIT) Misses Q3 EPS by 4c

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.64), $0.04 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Roth/MKM Downgrades eGain Corporation (EGAN) to Neutral
• JPMorgan Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral